CLEARMIND MEDICINE INC (CMND) Stock News

NASDAQ:CMND - Nasdaq - CA1850534027 - Common Stock - Currency: USD

1.02 0 (0%)

After market: 1.02 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CMND Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

7 days ago - By: SciSparc Ltd - Mentions: SPRC -

SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

7 days ago - By: Clearmind Medicine Inc. - Mentions: SPRC

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

9 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

9 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

15 days ago - By: Clearmind Medicine Inc. - Mentions: SPRC

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

15 days ago - By: SciSparc Ltd - Mentions: SPRC

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

22 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

22 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

a month ago - By: Clearmind Medicine Inc.

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

a month ago - By: Clearmind Medicine Inc.

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

3 months ago - By: Clearmind Medicine Inc. - Mentions: SPRC

Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

4 months ago - By: Yahoo Finance - Mentions: CMPS APPF ET KMI ...

Why Compass Pathways Stock Was a Double-Digit Winner This Week

4 months ago - By: SciSparc Ltd - Mentions: SPRC

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts